返回 Agenda
Session Chair(s)
Yoshiaki Uyama, PHD, MS, RPH
Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Speaker(s)
What is the right benefit/risk assessment?
Kazuhiko Mori, PHD, MSC
Japan Pharmaceutical Manufacturers Association (JPMA), Japan
Former Executive Director
New paradigm on benefit/risk evaluation
Masahiro Takeuchi, DRSC, MPH
Kitasato University School of Medicine, Japan
Professor,Dept. of Clinical Medicine (Biostatistics & Pharmaceutical Medicine)
A way to conduct the appropriate benefit/risk evaluation: Industry’s perspective
Hironobu Saito, PHD
Tottori University, Chromosome Egineering Research Center, Japan
Specially Appointed Professor